New Releases from NCBI BookshelfErdafitinib (Balversa): Therapeutic area: Locally advanced unresectable or metastatic urothelial carcinoma: Reimbursement Review [Internet].Erdafitinib (Balversa): Therapeutic area: Locally advanced unresectable or metastatic urothelial carcinoma: Reimbursement Review [Internet].
Post Content
